Syntheses and Structure−Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity against Drug-Resistant Cancer Cells

Wani M. C., 1971, J. Am. Chem. Soc., 93, 2327, 10.1021/ja00738a046

Guéritte-Voegelein F., 1990, Acta Crstallogr., 46, 784, 10.1107/S0108768190007480

Taxane Anticancer Agents, 1995, DC

Suffness, M. Taxol:  From Discovery to Therapeutic Use. InAnnual Reports in MedicinalChemistry; Bristol, J. A., Ed.; Academic Press:  San Diego, 1993; Vol. 28, Chapter 32, pp 305−314.

Suffness, M.Taxol:  Science and Applications; CRC Press:  New York, 1995.

Rowinsky E. K., 1992, Semin. Oncol., 19, 662

Guénard D., 1993, Acc. Chem. Res., 26, 167, 10.1021/ar00028a005

Shiff P. B., 1979, Nature, 277, 667, 10.1038/277667a0

Manfredi J. J., 1984, Pharmacol. Ther., 25, 125, 10.1016/0163-7258(84)90025-1

Ringel I., 1991, J. Natl. Cancer Inst., 83, 291, 10.1093/jnci/83.4.288

Seidman A. D., 1993, Stony Brook Symposium on Taxol and Taxotère; Stony Brook, NY, May 14−15

Arbuck, S. G.; Blaylock, B. A. Taxol:  Clinical Results and Current Issues in Development. InTaxol®:  Science and Applications; Suffness, M., Ed.; CRC Press:  Boca Raton, FL, 1995; pp 379−415.

Verweij J., 1994, Ann. Oncol., 5, 505

Georg G. I., 1995, Taxol®:  Science and Applications, 375

Nicolaou K. C., 1994, Angew. Chem., Int. Ed. Engl., 33, 44

Kingston D. G. I, 1991, Pharmacol. Ther., 52, 34

Ojima I., 1994, J. Org. Chem., 59, 517

Ojima I., 1994, J. Med. Chem., 37, 2608

Ojima I., 1994, Bioorg. Med. Chem. Lett., 4, 2634

Ojima I., 1994, Bioorg. Med. Chem. Lett., 4, 1576

Ojima I., 1994, J. Med. Chem., 37, 1408, 10.1021/jm00036a004

Ojima I., 1995, Taxane Anticancer Agents:  Basic Science and Current Status, 275

Kant J., 1994, Tetrahedron Lett., 35, 5546, 10.1016/S0040-4039(00)77242-X

Rao K. V., 1995, J. Med. Chem., 38, 3414

Ojima I, 1995, Acc. Chem. Res., 28, 389, 10.1021/ar00057a004

Ojima I., 1993, Bioorg. Med. Chem. Lett., 3, 2482, 10.1016/S0960-894X(01)80982-3

Ojima I., 1993, Tetrahedron Lett., 34, 4152, 10.1016/S0040-4039(00)60514-2

Ojima I., 1992, Tetrahedron, 48, 7012, 10.1016/S0040-4020(01)91210-4

Holton R. A., 1995, Taxol®:  Science and Applications, 121

Georg G. I., 1995, Structure-Acitivity Relationshipts, and Conformational Analysis. In Taxane Anticancer Agents:  Basic Science and Current Status, 232

Denis J.-N., 1988, J. Am. Chem. Soc., 110, 5919, 10.1021/ja00225a064

Chen S. H., 1994, Bioorg. Med. Chem. Lett., 4, 2228

Duggan M. E., 1989, Synthesis, 131, 10.1055/s-1989-27173

Holton R. A., 1994, J. Am. Chem. Soc., 116, 1600

Holton R. A., 1994, Tetrahedron Lett., 35, 1668, 10.1016/0040-4039(94)88314-9

Skehan P., 1990, J. Natl. Cancer Inst., 82, 1112, 10.1093/jnci/82.13.1107

Sikic B. I, 1993, J. Clin. Oncol., 11, 1635, 10.1200/JCO.1993.11.9.1629

Ojima I., 1995, J. Med. Chem., 38, 3894, 10.1021/jm00020a001

Geran R. I., 1972, Cancer Chemother. Rep. Part 3, 3, 103

Mangatal L., 1989, Tetrahedron, 45, 4190, 10.1016/S0040-4020(01)81313-2

Sharma A., 1995, J. Pharm. Sci., 84, 1404

Motulsky H. J., 1987, FASEB J., 1, 374, 10.1096/fasebj.1.5.3315805

Bissery M. C., 1991, Cancer Res., 51, 4852